Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- New study suggests Carnipure(TM) supplementation improves bone mineral density
A new study released by the University of Connecticut, USA, suggests, that Carnipure(TM) tartrate supplementation can slow down bone loss and improve bone microstructural properties by decreasing bone turnover in aged ovariectomized rats.
- New Study shows that Gamma-Tocotrienol is the most Cardioprotective Tocotrienol
In a recent study published in the AJP-Heart and Circulatory Physiology, 2008, researchers at the University of Connecticut School of Medicine, used various isomers of tocotrienols, supplied by Carotech Inc, to study the effects and mechanism of tocotrienols’ cardioprotective function especially on their ability to improve post-ischemic ventricular function and reduce myocardial infarct size in rats. The results showed that gamma-tocotrienol was the most cardioprotective of all the isomers.
- New Study shows that Gamma-Tocotrienol is the most Cardioprotective Tocotrienol
In a recent study published in the AJP-Heart and Circulatory Physiology, 2008, researchers at the University of Connecticut School of Medicine, used various isomers of tocotrienols, supplied by Carotech Inc, to study the effects and mechanism of tocotrienols’ cardioprotective function especially on their ability to improve post-ischemic ventricular function and reduce myocardial infarct size in rats. The results showed that gamma-tocotrienol was the most cardioprotective of all the isomers.
- New Study shows that Gamma-Tocotrienol is the most Cardioprotective Tocotrienol
In a recent study published in the AJP-Heart and Circulatory Physiology, 2008, researchers at the University of Connecticut School of Medicine, used various isomers of tocotrienols, supplied by Carotech Inc, to study the effects and mechanism of tocotrienols’ cardioprotective function especially on their ability to improve post-ischemic ventricular function and reduce myocardial infarct size in rats. The results showed that gamma-tocotrienol was the most cardioprotective of all the isomers.
- 5-LOXIN® proven to reduce the symptoms of osteoarthritis in new human study published in Arthritis Research and Therapy
a new study published in Arthritis Research & Therapy examines the use of 5-LOXIN®, with researchers observing clinically and statistically significant improvements in pain scores and physical function scores in OA patients at doses of 100mg and 250mg daily.
- 5-LOXIN® proven to reduce the symptoms of osteoarthritis in new human study published in Arthritis Research and Therapy
a new study published in Arthritis Research & Therapy examines the use of 5-LOXIN®, with researchers observing clinically and statistically significant improvements in pain scores and physical function scores in OA patients at doses of 100mg and 250mg daily.
- 5-LOXIN® proven to reduce the symptoms of osteoarthritis in new human study published in Arthritis Research and Therapy
a new study published in Arthritis Research & Therapy examines the use of 5-LOXIN®, with researchers observing clinically and statistically significant improvements in pain scores and physical function scores in OA patients at doses of 100mg and 250mg daily.
- Aquapharm and Croda International Sign Three Year Research Collaboration Agreement
Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care.
- Aquapharm and Croda International Sign Three Year Research Collaboration Agreement
Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care.
- Aquapharm and Croda International Sign Three Year Research Collaboration Agreement
Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care.
- Aquapharm and Croda International Sign Three Year Research Collaboration Agreement
Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care.
- Pediatrics Journal Publishes Positive Safety Results of First Children's Trial Involving COLD-fX(R)
Pediatrics - the official journal of the American Academy of Pediatrics, has published safety results of a children's randomized, double-blind, placebo-controlled clinical trial involving COLD-fX®. The trial, designed to measure safety and tolerability, showed COLD-fX is safe for children.
- Pediatrics Journal Publishes Positive Safety Results of First Children's Trial Involving COLD-fX(R)
Pediatrics - the official journal of the American Academy of Pediatrics, has published safety results of a children's randomized, double-blind, placebo-controlled clinical trial involving COLD-fX®. The trial, designed to measure safety and tolerability, showed COLD-fX is safe for children.
- Pediatrics Journal Publishes Positive Safety Results of First Children's Trial Involving COLD-fX(R)
Pediatrics - the official journal of the American Academy of Pediatrics, has published safety results of a children's randomized, double-blind, placebo-controlled clinical trial involving COLD-fX®. The trial, designed to measure safety and tolerability, showed COLD-fX is safe for children.
- Enzymedica’s Free Radical Defenze(TM) Subject of First-place Scientific Poster Recognition at NPA Show
Enzymedica, Inc. has announced that a comparative analysis of its recently launched Free Radical Defenze(TM) antioxidant enzyme supplement received first-place honors in the Scientific Poster Session held Friday, July 18 at The Natural Products Association's Natural MarketPlace 2008 in Las Vegas, Nev.
- Enzymedica’s Free Radical Defenze(TM) Subject of First-place Scientific Poster Recognition at NPA Show
Enzymedica, Inc. has announced that a comparative analysis of its recently launched Free Radical Defenze(TM) antioxidant enzyme supplement received first-place honors in the Scientific Poster Session held Friday, July 18 at The Natural Products Association's Natural MarketPlace 2008 in Las Vegas, Nev.
- Enzymedica’s Free Radical Defenze(TM) Subject of First-place Scientific Poster Recognition at NPA Show
Enzymedica, Inc. has announced that a comparative analysis of its recently launched Free Radical Defenze(TM) antioxidant enzyme supplement received first-place honors in the Scientific Poster Session held Friday, July 18 at The Natural Products Association's Natural MarketPlace 2008 in Las Vegas, Nev.
- Enzymedica’s Free Radical Defenze(TM) Subject of First-place Scientific Poster Recognition at NPA Show
Enzymedica, Inc. has announced that a comparative analysis of its recently launched Free Radical Defenze(TM) antioxidant enzyme supplement received first-place honors in the Scientific Poster Session held Friday, July 18 at The Natural Products Association's Natural MarketPlace 2008 in Las Vegas, Nev.
- Pharmanex Study Correlates Skin Carotenoids to Overall Antioxidant Health
Scientists from Nu Skin Enterprises, Inc. (NUS) , presented results and consistency of findings from two large studies at the 15th International Symposium on Carotenoids in Okinawa, Japan, indicating that skin carotenoid levels measured with the Pharmanex(R) BioPhotonic Scanner correlate with, and are a good indication of, the body's overall antioxidant defense system.
- Pharmanex Study Correlates Skin Carotenoids to Overall Antioxidant Health
Scientists from Nu Skin Enterprises, Inc. (NUS) , presented results and consistency of findings from two large studies at the 15th International Symposium on Carotenoids in Okinawa, Japan, indicating that skin carotenoid levels measured with the Pharmanex(R) BioPhotonic Scanner correlate with, and are a good indication of, the body's overall antioxidant defense system.
- InterMed Discovery achieves Proof-of-Principle for IMD-026260
InterMed Discovery GmbH has announced that it has established proof-of-principle in a pre-clinical study for its optimized lead compound IMD-026260, an anti-cancer drug candidate.
- InterMed Discovery achieves Proof-of-Principle for IMD-026260
InterMed Discovery GmbH has announced that it has established proof-of-principle in a pre-clinical study for its optimized lead compound IMD-026260, an anti-cancer drug candidate.
- InterMed Discovery achieves Proof-of-Principle for IMD-026260
InterMed Discovery GmbH has announced that it has established proof-of-principle in a pre-clinical study for its optimized lead compound IMD-026260, an anti-cancer drug candidate.
- Potassium Increases May Lower Blood Pressure
A study in the July issue of the Journal of Clinical Hypertension has found that there is a potential link between increased levels of potassium and the lowering of blood pressure in adults.
- Potassium Increases May Lower Blood Pressure
A study in the July issue of the Journal of Clinical Hypertension has found that there is a potential link between increased levels of potassium and the lowering of blood pressure in adults.
- Potassium Increases May Lower Blood Pressure
A study in the July issue of the Journal of Clinical Hypertension has found that there is a potential link between increased levels of potassium and the lowering of blood pressure in adults.
- Potassium Increases May Lower Blood Pressure
A study in the July issue of the Journal of Clinical Hypertension has found that there is a potential link between increased levels of potassium and the lowering of blood pressure in adults.
- Potassium Increases May Lower Blood Pressure
A study in the July issue of the Journal of Clinical Hypertension has found that there is a potential link between increased levels of potassium and the lowering of blood pressure in adults.
- Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans
A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing.
- Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans
A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing.
- Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans
A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing.
- Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans
A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing.
- Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans
A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing.
- Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans
A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing.
- Produce Power: Cancer-Fighting Carrots, Tomatoes, and Beans
A study published in the International Journal of Cancer said that people who eat more vegetables and fruits had a lower risk of head and neck cancers developing.
- ABC Releases Monograph on Scientific Research of POM Wonderful® Pomegranate Juice
The nonprofit American Botanical Council (ABC) has recently released a monograph on the published scientific and clinical studies relating to POM Wonderful® Pomegranate Juice.
- ABC Releases Monograph on Scientific Research of POM Wonderful® Pomegranate Juice
The nonprofit American Botanical Council (ABC) has recently released a monograph on the published scientific and clinical studies relating to POM Wonderful® Pomegranate Juice.
- ABC Releases Monograph on Scientific Research of POM Wonderful® Pomegranate Juice
The nonprofit American Botanical Council (ABC) has recently released a monograph on the published scientific and clinical studies relating to POM Wonderful® Pomegranate Juice.
- ABC Releases Monograph on Scientific Research of POM Wonderful® Pomegranate Juice
The nonprofit American Botanical Council (ABC) has recently released a monograph on the published scientific and clinical studies relating to POM Wonderful® Pomegranate Juice.
- ABC Releases Monograph on Scientific Research of POM Wonderful® Pomegranate Juice
The nonprofit American Botanical Council (ABC) has recently released a monograph on the published scientific and clinical studies relating to POM Wonderful® Pomegranate Juice.
- ABC Releases Monograph on Scientific Research of POM Wonderful® Pomegranate Juice
The nonprofit American Botanical Council (ABC) has recently released a monograph on the published scientific and clinical studies relating to POM Wonderful® Pomegranate Juice.
- ABC Releases Monograph on Scientific Research of POM Wonderful® Pomegranate Juice
The nonprofit American Botanical Council (ABC) has recently released a monograph on the published scientific and clinical studies relating to POM Wonderful® Pomegranate Juice.
- Newly Published U.S. Military Research Demonstrates that Hemp Foods Don't Contain Significant Amounts of the Drug THC
The findings of the new research, published in the July/August 2008 Journal of Analytical Toxicology, indicate that not only do hemp products in the marketplace not contain hemp at levels that would cause intoxication or failed drug tests, the vast majority of the tests did not detect any THC.
- Newly Published U.S. Military Research Demonstrates that Hemp Foods Don't Contain Significant Amounts of the Drug THC
The findings of the new research, published in the July/August 2008 Journal of Analytical Toxicology, indicate that not only do hemp products in the marketplace not contain hemp at levels that would cause intoxication or failed drug tests, the vast majority of the tests did not detect any THC.
- Newly Published U.S. Military Research Demonstrates that Hemp Foods Don't Contain Significant Amounts of the Drug THC
The findings of the new research, published in the July/August 2008 Journal of Analytical Toxicology, indicate that not only do hemp products in the marketplace not contain hemp at levels that would cause intoxication or failed drug tests, the vast majority of the tests did not detect any THC.
- Newly Published U.S. Military Research Demonstrates that Hemp Foods Don't Contain Significant Amounts of the Drug THC
The findings of the new research, published in the July/August 2008 Journal of Analytical Toxicology, indicate that not only do hemp products in the marketplace not contain hemp at levels that would cause intoxication or failed drug tests, the vast majority of the tests did not detect any THC.
- Newly Published U.S. Military Research Demonstrates that Hemp Foods Don't Contain Significant Amounts of the Drug THC
The findings of the new research, published in the July/August 2008 Journal of Analytical Toxicology, indicate that not only do hemp products in the marketplace not contain hemp at levels that would cause intoxication or failed drug tests, the vast majority of the tests did not detect any THC.
- Newly Published U.S. Military Research Demonstrates that Hemp Foods Don't Contain Significant Amounts of the Drug THC
The findings of the new research, published in the July/August 2008 Journal of Analytical Toxicology, indicate that not only do hemp products in the marketplace not contain hemp at levels that would cause intoxication or failed drug tests, the vast majority of the tests did not detect any THC.
- Newly Published U.S. Military Research Demonstrates that Hemp Foods Don't Contain Significant Amounts of the Drug THC
The findings of the new research, published in the July/August 2008 Journal of Analytical Toxicology, indicate that not only do hemp products in the marketplace not contain hemp at levels that would cause intoxication or failed drug tests, the vast majority of the tests did not detect any THC.
- Newly Published U.S. Military Research Demonstrates that Hemp Foods Don't Contain Significant Amounts of the Drug THC
The findings of the new research, published in the July/August 2008 Journal of Analytical Toxicology, indicate that not only do hemp products in the marketplace not contain hemp at levels that would cause intoxication or failed drug tests, the vast majority of the tests did not detect any THC.
- AOAC Approves First Ever Method For Simultaneous Detection of Mycotoxins in Ginseng and Ginger
Vicam has announced that the AOAC International has awarded Official MethodSM First Action status to the protocol “Determination of Aflatoxins B1, B2, G1 and G2 and Ochratoxin A in Ginseng and Ginger by Multi-toxin Immunoaffinity Column Clean-up and Liquid Chromatographic Quantitation.” The newly approved method is applicable for use with powdered ginseng and ginger, botanical products which are widely available to consumers.
- AOAC Approves First Ever Method For Simultaneous Detection of Mycotoxins in Ginseng and Ginger
Vicam has announced that the AOAC International has awarded Official MethodSM First Action status to the protocol “Determination of Aflatoxins B1, B2, G1 and G2 and Ochratoxin A in Ginseng and Ginger by Multi-toxin Immunoaffinity Column Clean-up and Liquid Chromatographic Quantitation.” The newly approved method is applicable for use with powdered ginseng and ginger, botanical products which are widely available to consumers.
- AOAC Approves First Ever Method For Simultaneous Detection of Mycotoxins in Ginseng and Ginger
Vicam has announced that the AOAC International has awarded Official MethodSM First Action status to the protocol “Determination of Aflatoxins B1, B2, G1 and G2 and Ochratoxin A in Ginseng and Ginger by Multi-toxin Immunoaffinity Column Clean-up and Liquid Chromatographic Quantitation.” The newly approved method is applicable for use with powdered ginseng and ginger, botanical products which are widely available to consumers.
- NIH's Office of Dietary Supplements and National Library of Medicine to Test Dietary Supplement Label Database for Researchers and Consumers
A partnership between the Office of Dietary Supplements and the National Library of Medicine has been made in order to put together a study which will determine the feasibilty of creating a Web-based catalogue of labels from all dietary supplements sold in the US.
- NIH's Office of Dietary Supplements and National Library of Medicine to Test Dietary Supplement Label Database for Researchers and Consumers
A partnership between the Office of Dietary Supplements and the National Library of Medicine has been made in order to put together a study which will determine the feasibilty of creating a Web-based catalogue of labels from all dietary supplements sold in the US.
- Inhibition of Protein Glycation by Extracts of Culinary Herbs and Spices
A paper in the Journal of Medicinal Health describes researchers attempting to see “whether polyphenolic substances in extracts of commercial culinary herbs and spices would inhibit fructose-mediated protein glycation.” In short, the study was searching for a correlation between extracts from household spices and a lowering of effects from raised blood sugar levels in diabetics.
- Inhibition of Protein Glycation by Extracts of Culinary Herbs and Spices
A paper in the Journal of Medicinal Health describes researchers attempting to see “whether polyphenolic substances in extracts of commercial culinary herbs and spices would inhibit fructose-mediated protein glycation.” In short, the study was searching for a correlation between extracts from household spices and a lowering of effects from raised blood sugar levels in diabetics.
- Inhibition of Protein Glycation by Extracts of Culinary Herbs and Spices
A paper in the Journal of Medicinal Health describes researchers attempting to see “whether polyphenolic substances in extracts of commercial culinary herbs and spices would inhibit fructose-mediated protein glycation.” In short, the study was searching for a correlation between extracts from household spices and a lowering of effects from raised blood sugar levels in diabetics.
- New Study Confirms Carnipure™ Tartrate Supplementation Decreases Hypoxic Stress Following Resistance Exercise
A new company-supported study from the same research group was released in the July 2008 issue of the Journal of Strength and Conditioning Research, with results showing Carnipure™ tartrate actually induces an increase in muscle oxygen consumption, providing a potential mechanism for reduced hypoxic stress following resistance exercise.
- New Study Confirms Carnipure™ Tartrate Supplementation Decreases Hypoxic Stress Following Resistance Exercise
A new company-supported study from the same research group was released in the July 2008 issue of the Journal of Strength and Conditioning Research, with results showing Carnipure™ tartrate actually induces an increase in muscle oxygen consumption, providing a potential mechanism for reduced hypoxic stress following resistance exercise.
- New Study Confirms Carnipure™ Tartrate Supplementation Decreases Hypoxic Stress Following Resistance Exercise
A new company-supported study from the same research group was released in the July 2008 issue of the Journal of Strength and Conditioning Research, with results showing Carnipure™ tartrate actually induces an increase in muscle oxygen consumption, providing a potential mechanism for reduced hypoxic stress following resistance exercise.
- New Study Confirms Carnipure™ Tartrate Supplementation Decreases Hypoxic Stress Following Resistance Exercise
A new company-supported study from the same research group was released in the July 2008 issue of the Journal of Strength and Conditioning Research, with results showing Carnipure™ tartrate actually induces an increase in muscle oxygen consumption, providing a potential mechanism for reduced hypoxic stress following resistance exercise.
- Research Presented at the AHCC International Research Symposium Shows Potential Cancer Preventative Effects
The 16th International AHCC® (Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on July 26th and 27th, attended by over 300 medical doctors and researchers from around the world that presented and discussed research studies completed with AHCC. Researchers at Yale, in collaboration with researchers in Japan, have confirmed that AHCC significantly enhances the immune system in a manner that may prove significant for healthy immune function and as a cancer preventative for older Americans.
- Research Presented at the AHCC International Research Symposium Shows Potential Cancer Preventative Effects
The 16th International AHCC® (Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on July 26th and 27th, attended by over 300 medical doctors and researchers from around the world that presented and discussed research studies completed with AHCC. Researchers at Yale, in collaboration with researchers in Japan, have confirmed that AHCC significantly enhances the immune system in a manner that may prove significant for healthy immune function and as a cancer preventative for older Americans.
- Research Presented at the AHCC International Research Symposium Shows Potential Cancer Preventative Effects
The 16th International AHCC® (Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on July 26th and 27th, attended by over 300 medical doctors and researchers from around the world that presented and discussed research studies completed with AHCC. Researchers at Yale, in collaboration with researchers in Japan, have confirmed that AHCC significantly enhances the immune system in a manner that may prove significant for healthy immune function and as a cancer preventative for older Americans.
- Research Presented at the AHCC International Research Symposium Shows Potential Cancer Preventative Effects
The 16th International AHCC® (Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on July 26th and 27th, attended by over 300 medical doctors and researchers from around the world that presented and discussed research studies completed with AHCC. Researchers at Yale, in collaboration with researchers in Japan, have confirmed that AHCC significantly enhances the immune system in a manner that may prove significant for healthy immune function and as a cancer preventative for older Americans.
- Sabinsa's Curcumin C3 Complex(R) Subject of Recent Pancreatic Cancer Study
A recent University of Texas – MD Anderson Cancer Center study was published in the peer review American Association for Cancer Research's journal "Clinical Cancer Research" 14.14 (July 2008). Results of an eight-week human, phase II trial of the patented ingredient Curcumin C3 Complex(R) by Sabinsa, indicated orally-ingested curcumin is well-tolerated in pancreatic cancer patients and, despite limited absorption, curcuminoids showed biological efficacy in some patients with pancreatic cancer.
- Sabinsa's Curcumin C3 Complex(R) Subject of Recent Pancreatic Cancer Study
A recent University of Texas – MD Anderson Cancer Center study was published in the peer review American Association for Cancer Research's journal "Clinical Cancer Research" 14.14 (July 2008). Results of an eight-week human, phase II trial of the patented ingredient Curcumin C3 Complex(R) by Sabinsa, indicated orally-ingested curcumin is well-tolerated in pancreatic cancer patients and, despite limited absorption, curcuminoids showed biological efficacy in some patients with pancreatic cancer.
- Sabinsa's Curcumin C3 Complex(R) Subject of Recent Pancreatic Cancer Study
A recent University of Texas – MD Anderson Cancer Center study was published in the peer review American Association for Cancer Research's journal "Clinical Cancer Research" 14.14 (July 2008). Results of an eight-week human, phase II trial of the patented ingredient Curcumin C3 Complex(R) by Sabinsa, indicated orally-ingested curcumin is well-tolerated in pancreatic cancer patients and, despite limited absorption, curcuminoids showed biological efficacy in some patients with pancreatic cancer.
- Animal Study Indicates Grape Seed Extract May Reduce Cognitive Decline Associated With Alzheimer’s Disease
A compound found in grape seed extract reduces plaque formation and resulting cognitive impairment in an animal model of Alzheimer’s disease, new research shows. The study appears in the June 18 issue of The Journal of Neuroscience. The study found that the grape seed extract prevents amyloid beta accumulation in cells, suggesting that it may block the formation of abnormally high molecular weight soluble oligomerized amyloid peptides highly implicated in mechanism associated with deterioration of cognitive functions and eventually dementia in Alzheimer’s disease.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Supplementing with vitamin D early in life may reduce the chances of developing type 1 diabetes later on, according to a new study published in the Archives of Disease in Childhood.
Recent research has shown that vitamin D, well known for its important role in bone health, may be essential for many other aspects of health as well, including heart health and the prevention of chronic diseases such as cancer and multiple sclerosis. To determine the impact of early vitamin D supplementation on the development of type 1 diabetes, the authors reviewed five studies, which included 6,455 people who were followed from the time of supplementation to an average age of 15 years, and some for as long as 30 years.
A strong association
Type 1 diabetes risk was significantly reduced in babies who were given vitamin D compared with those who did not receive supplementation. Among those who were given vitamin D, those who received higher amounts were at even lower risk than children taking lower amounts. The authors noted that timing of supplementation may also be important, as children who received vitamin D between 7 to 12 months of age had a lower risk of developing type 1 diabetes compared with children who received it between 0 and 6 months. Children who received regular as opposed to irregular supplementation had a further reduced risk.
Types and dosages of supplementation varied among the reviewed studies. One study used cod liver oil from one to more than five times per week, and another study recommended regular supplementation with 2,000 IU of vitamin D per day.
“The results of the study suggest that vitamin D supplementation in infancy may offer protection against the development of type 1 diabetes,” said Christos Zipitis and his colleague from the Department of Pediatrics at Manchester Children’s University Hospitals, Manchester, United Kingdom. They found that children given vitamin D had a 29% reduced risk of developing type 1 diabetes compared with those who were not given supplements.
Good for the immune system
Type 1 diabetes is a serious condition caused by the destruction of cells in the pancreas that secrete insulin. When these cells are destroyed, the body lacks insulin and blood sugar levels rise. Because high blood sugar can lead to many serious health conditions, people with type 1 diabetes must take insulin in order to lower their blood sugar. The destruction of pancreatic tissue that leads to type 1 diabetes is thought to be due to a dysfunctional immune system. Vitamin D may help prevent type 1 diabetes by keeping the immune system healthy, although the exact mechanism by which the vitamin may be protective is not known.
Vitamin D may be obtained through sun exposure, diet, and supplementation. Dietary sources include fish, cod liver oil, and fortified milk. Check with your child’s pediatrician to find out the latest recommendations regarding vitamin D and the health of your child.
Jane Hart, MD |